Glucose & Insulin Response Combined GLP-1 and GIP activity improves insulin sensitivity and glucose-dependent insulin release, addressing the metabolic root rather than calories alone
doi: 10.1007/s00726-020-02909-1
Thus, the multifaceted nature of this drug may allow for a holistic approach to treatment
These compounds work through entirely different mechanisms, making direct comparison difficult
What makes Ipamorelin unique: Mimics natural HGH release patterns more closely Doesn't significantly affect cortisol or prolactin (unlike some other GHRPs) Very clean side effect profile Often called the "gold standard" of HGH alternatives for safety Benefits relevant to menopause: Improved muscle mass and strength Reduced body fat, particularly abdominal Better bone density Enhanced sleep quality Improved cognitive function Better immune function Typical protocol: Dose: 200-300 mcg subcutaneously Timing: Before bed or in divided doses (morning and evening) Frequency: Daily Cycle length: 8-12 weeks on, 4 weeks off, or continuous at lower doses CJC-1295 CJC-1295 is another GHRH analog, often used in combination with Ipamorelin for synergistic effects
Nat Rev Cancer (2013) 13(3):18499
